Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 2, 2003, Pages 636-642

  Suchland, R J ^a   Geisler, W M ^a   Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; OFLOXACIN; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL CULTURE; CELL LINE; CELL SURVIVAL; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; HUMAN CELL; IN VITRO STUDY; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CHLAMYDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

EID: 0037309744     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.2.636-642.2003     Document Type: Article

References (30)

1. Andersen, A. A., and K. G. Rogers. 1998. Resistance to tetracycline and sulfadiazine in swine C. trachomatis isolates, p. 313-316. In R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgeway, P. Saikku, J. Schachter, and W. E. Stamm (ed.), Chlamydial infections. Proceedings of the 9th International Symposium on Human Chlamydial Infection, Napa, Calif. Berkeley University Press, Berkeley, Calif.
2. Barnes, R. C., R. E. Roddy, and W. E. Stamm. 1986. Serovars of Chlamydia trachomatis causing repeated genital infection, p. 503-507. In D. Oriel, G. Ridgway, J. Schachter, D. Taylor-Robinson, and M. Ward (ed.), Chlamydial infections. Cambridge University Press, Cambridge, United Kingdom.
3. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998-4002.
4. Blythe, M. J., B. P. Katz, B. E. Batteiger, J. A. Ganser, and R. B. Jones. 1992. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J. Pediatr. 121:487-493.
5. Catalan, F., A. Milovanovic, C. Prouteau, and M. Soulignac. 1998. Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated form gynecologic infections. Pathol. Biol. (Paris) 46:144-146.
6. Cates, W. 1999. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 26(Suppl.):S2-S7.
7. Centers for Disease Control and Prevention. 1995. Chlamydia trachomatis genital infections-United States. Morb. Mortal. Wkly. Rep. 46:193-198.
8. Cross, N. A., D. J. Kellock, G. R. Kinghorn, M. Taraktchoglou, E. Bataki, K. M. Oxley, P. M. Hawkey, and A. Eley. 1999. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. Antimicrob. Agents Chemother. 43:2311-2313.
9. Dean, D., R. J. Suchland, and W. E. Stamm. 2000. Evidence of long-term cervical persistence of C. trachomatis by ompl genotyping. J. Infect. Dis. 182:909-916.
10. Dessus-Babus, S., C. M. Bébéar, A. Charron, C. Bébéar, and B. De Barbeyrac. 1998. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro. Antimicrob. Agents Chemother. 42:2474-2481.
11. Donati, M., F. M. Rodriguez, A. Olmo, L. D'Apote, and R. Cevenini. 1999. Comparative in-vitro activity of moxifloxacin, minocycline, and azithromycin against Chlamydia spp. J. Antimicrob. Chemother. 43:825-827.
12. Dreses-Werringloer, U., I. Padubrin, H. Zeidler, and L. Köhler. 2000. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob. Agents Chemother. 45:3001-3008.
13. Gladue, R. P., and M. E. Snider. 1990. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob. Agents Chemother. 34: 1056-1060.
14. Institute of Medicine. 1997. The hidden epidemic: confronting sexually transmitted diseases. National Academy Press, Washington, D.C.
15. Jones, R. B., B. Vander Der Pol, D. H. Martin, and M. K. Shepard. 1990. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J. Infect. Dis. 162:1309-1315.
16. Kagnoff, M. F., and L. Eckmann. 1997. Epithelial cells as sensors for microbial infection. J. Clin. Investig. 100:6-10.
17. Keshishyan, K., L. Hanna, and E. Jawefz. 1973. Emergence of rifampin resistance in Chlamydia trachomatis. Nature 244:173-174.
18. Lefevre, J. C., J. P. Lepargneur, D. Guion, and S. Bei. 1997. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France. Pathol. Biol. 45:376-378.
19. Lenart, J., A. A. Andersen, and D. D. Rockey. 2000. Growth and development of tetracycline-resistant Chlamydia suis. Antimicrob. Agents Chemother. 45: 2198-2203.
20. Morrisey, C., I. H. Salman, S. Bakker, D. Farrell, C. M. Bebear, and G. Ridgway. 2002. Serial passage of chlamydia spp. in subinhibitory fluoroquinolone concentrations. J. Antimicrob. Chemother. 49:757-761.
21. Notomi, T., Y. Ikeda, and A. Nagayama. 1999. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and duration of the presence of antibiotics. Chemotherapy 45:242-248.
22. Parks, K. S., P. B. Dixon, C. M. Richey, and E. W. Hook III. 1997. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. 24:229-235.
23. Pedersen, L. N., H. O. Kjær, J. K. Møller, T. F. Ørntoft, and L. Ostergaard. 2000. High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J. Clin. Microbiol. 38:3068-3071.
24. Rasmussen, S. J., P. Timms, P. R. Beatty, and R. S. Stephens. 1996. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp. Infect. Immun. 64:1944-1949.
25. Ridgway, G. L., J. M. Owen, and J. D. Oriel. 1976. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system. J. Antimicrob. Chemother. 2:71-76.
26. Rota, T. R. 1980. Techniques for culturing and determining antimicrobial susceptibility of Chlamydia trachomatis. Arch. Androl. 4:63-69.
27. Somani, J., V. B. Bhullar, K. A. Workowski, C. E. Farshy, and C. M. Black. 2000. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181:1421-1427.
28. Stamm, W. E. 2000. Potential for antimicrobial resistance in Chlamydia pneumoniae. J. Infect. Dis. 181(Suppl.):S456-S459.
29. Wyrick, P. B., C. H. Davis, S. T. Knight, and J. Choong. 1993. In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells. J. Antimicrob. Chemother. 31:139-150.
30. Wyrick, P. B., C. H. Davis, J. E. Raulston, S. T. Knight, and J. Choong. 1994. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis. Clin. Infect Dis. 19:931-936.